VAERS reports by lot

GSK DTaP/Tdap lot 58160-0842-52: VAERS reports

20 VAERS reports list lot 58160-0842-52 as a GSK DTaP/Tdap vaccine, received between 2016-05-13 and 2024-11-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
5%
Marked serious
0
With a death outcome
19
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2925%
Neurological2521%
Musculoskeletal1916%
Cardiac / Cardiovascular109%
Gastrointestinal109%
Injection-site / Local reaction98%
Dermatological (non-injection-site)76%
Allergic / Anaphylactic43%
Respiratory22%
Thrombotic / Hematological11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas2
California2
Michigan2
Florida1
Illinois1
Alabama1
Virginia1
New Jersey1
Pennsylvania1
Utah1
Ohio1
Indiana1

Reports by month received

2016-051
2016-061
2016-091
2017-022
2019-081
2020-031
2020-091
2020-101
2020-111
2021-061
2021-071
2021-111
2022-071
2022-101
2022-121
2023-011
2023-021
2023-091
2024-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.